title: [New pharmaceuticals in treatment of chronic dust bronchitis].
abstract: The study was dedicated to the assessment of the therapeutic possibilities provided by erespal (fenspirid) as a new class of pharmaceuticals inhibiting the inflammatory process, in patients with chronic dust bronchitis.
authors.forename: V V
authors.initials: VV
authors.lastname: Kosarev
authors.forename: N V
authors.initials: NV
authors.lastname: Vakurova
authors.forename: S A
authors.initials: SA
authors.lastname: Babanov
mesh_terms: D000328:Adult; D001991:Bronchitis / Q000188:drug therapy* / Q000209:etiology*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D004391:Dust; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009784:Occupational Diseases / Q000188:drug therapy* / Q000209:etiology*; D016273:Occupational Exposure / Q000009:adverse effects*; D013141:Spiro Compounds / Q000627:therapeutic use*
chemical_list: D001993:Bronchodilator Agents; D004391:Dust; D013141:Spiro Compounds; C084775:fenspiride